Serum neurofilament light chain as a reliable biomarker of hereditary transthyretin-related amyloidosis - A Swiss reference center experience.

Valentin LoserPascal BenkertAlex VicinoPansy Lim Dubois FerrièreThierry KuntzerJérôme PasquierAleksandra MaceskiJens KuhleMarie Théaudin

Published in: Journal of the peripheral nervous system : JPNS (2022)

sNfL seems to be a reliable biomarker of peripheral neuropathy severity in hATTR amyloidosis and can distinguish between asymptomatic and symptomatic patients. sNfL could also become a reliable biomarker to establish disease onset and treatment response. This article is protected by copyright. All rights reserved.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
multiple myeloma
peritoneal dialysis
cerebrospinal fluid
patient reported outcomes
drug induced